S971-0522 Screening compound: 7-[3-(4-methoxyphenyl)-1H-pyrazole-4-carbonyl]-7-azaspiro[3.5]nonan-1-ol

S971-0522 Screening compound: 7-[3-(4-methoxyphenyl)-1H-pyrazole-4-carbonyl]-7-azaspiro[3.5]nonan-1-ol
S971-0522 Screening compound: 7-[3-(4-methoxyphenyl)-1H-pyrazole-4-carbonyl]-7-azaspiro[3.5]nonan-1-ol alternative view

Chemical Structure Depiction of ChemDiv screening compound S971-0522
7-[3-(4-methoxyphenyl)-1H-pyrazole-4-carbonyl]-7-azaspiro[3.5]nonan-1-ol

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S971-0522

Molecular Formula

C19H23N3O3 (C19 H23 N3 O3)

Compound Name

7-[3-(4-methoxyphenyl)-1H-pyrazole-4-carbonyl]-7-azaspiro[3.5]nonan-1-ol

IUPAC name

7-[3-(4-methoxyphenyl)-1H-pyrazole-4-carbonyl]-7-azaspiro[3.5]nonan-1-ol

SMILES

COc(cc1)ccc1-c1n[nH]cc1C(N(CC1)CCC1(CC1)C1O)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

341.41

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

1.392

Distribution Coefficient, logD

1.392

Water Solubility, LogSw

-2.16

Polar Surface Area

64.488

Acid Dissociation Constant (pKa)

11.78

Base Dissociation Constant (pKb)

0.21

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

47.37

S971-0522 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Soluble Diversity Library (15920 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
Mechanism of action:
  • PPI modulators
  • PPI modulators
Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with S971-0522 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S971-0522?
Check Price and Availability of S971-0522, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S971-0522 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S971-0522
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S971-0522
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S971-0522 available by request